Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar 7;10(3):156.
doi: 10.3390/brainsci10030156.

Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies

Claudia Brogna  1   2 , Marco Luigetti  3 , Giulia Norcia  1 , Roberta Scalise  1 , Gloria Ferrantini  1 , Beatrice Berti  1 , Domenico M Romeo  4 , Raffaele Manna  5 , Eugenio Mercuri  1 , Marika Pane  1
Affiliations
Case Reports

Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies

Claudia Brogna et al. Brain Sci. .

Abstract

We report the clinical case of a nine-year-old girl who presented with progressive motor neuropathy, revealed via the detection of a higher delay in F-wave recording using digitalized nerve conduction/electromyography. Since the lupus anticoagulant (LAC) positivity, detected using diluted Russell viper venom time (dRVVT), switched to persistent serological anticardiolipin immunoglobulin G (IgG) positivity, a possible non-thrombotic antiphospholipid antibody (aPL)-related clinical manifestation was suspected, and intravenous immunoglobulin treatment (IVIG) was started. The IVIG treatment was well tolerated and the complete resolution of motor impairment was obtained after the third IVIG infusion. Our findings suggest that it could be useful to check for antiphospholipid antibodies in children with a rapid onset of progressive neurological signs in order to provide the beneficial use of IVIG in the treatment of pediatric aPL neurological conditions.

Keywords: IVIG; antiphospholipid antibodies; pediatric motor neuropathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Dale R.C., Yin K., Ding A., Merheb V., Varadkhar S., McKay D., Singh-Grewal D., Brilot F. Antibody binding to neuronalsurface in movement disorders associated with lupus and antiphospholipid antibodies. Dev. Med. Child Neurol. 2011;53:522–528. doi: 10.1111/j.1469-8749.2011.03922.x. - DOI - PubMed
    1. Verschueren A. Motor neuropathies and lower motor neuron syndromes. Rev. Neurol. 2017;173:320–325. doi: 10.1016/j.neurol.2017.03.018. - DOI - PubMed
    1. Montes J., McDermott M.P., Martens W.B., Dunaway S., Glanzman A.M., Riley S., Quigley J., Montgomery M.J., Sproule D., Tawil R., et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 2010;74:833–838. doi: 10.1212/WNL.0b013e3181d3e308. - DOI - PMC - PubMed
    1. Scott E., Mawson S.J. Measurement in Duchenne muscular dystrophy: Considerations in the development of a neuromuscular assessment tool. Dev. Med. Child Neurol. 2006;48:540–544. doi: 10.1017/S0012162206001137. - DOI - PubMed
    1. Main M., Kairon H., Mercuri E., Muntoni F. The Hammersmith Functional Motor Scale for Children with spinal muscular atrophy: A scale to test ability and monitor progress in children with limited ambulation. Eur. J. Paediatr. Neurol. 2003;7:155–159. doi: 10.1016/S1090-3798(03)00060-6. - DOI - PubMed

Publication types

LinkOut - more resources